Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
05/2003
05/28/2003CN1420882A Substd. oxoazaheterocyclyl compounds
05/28/2003CN1420881A Beta-amino acid derivs. as inhibitors of matrix metalloproteases and TNF-alpha
05/28/2003CN1420878A Compound with growth hormone releasing properties
05/28/2003CN1420872A Caspase inhibitors and use thereof
05/28/2003CN1420770A Method of delivery of cetyl myristoleate
05/28/2003CN1419936A Blood substitute of hemoglobin microcapsule and preparing method thereof
05/28/2003CN1109549C Soft concentrated fish oil capsule and its supercritical CO2 extraction and rectification process
05/28/2003CN1109547C Antithrombotic and antiatherogenic pharmaceutical composition including thienopyridine deriv. and HMG-CoA reductase inhibitor
05/28/2003CN1109545C Formulation for iron chelation and process for preparing same
05/27/2003US6570002 Inhibitor of programmed cell death
05/27/2003US6569992 Protein for use in the treatment of immunological, liver, reproductive and infectious disorders
05/27/2003US6569904 Via administration of toremifene for treatment or prevention of systemic/pulmonary hypertension, fibrosis, bronchial asthma, respiratory distress syndrome, myocardial infarction, thrombosis, congestive heart failure, and renal failure
05/27/2003US6569896 Useful for oral testosterone replacement therapy, male contraception, maintaining sexual desire in women, treating prostate cancer and imaging prostate cancer
05/27/2003US6569871 Substituted imidazole compounds
05/27/2003US6569468 Treatment of urogenital disorders, menstrual cramps
05/27/2003US6569463 Encapsulation coat includes different combinations of pharmaceutical active ingredients, hydrophilic and lipophilic surfactants, and triglycerides
05/27/2003US6569446 Solubilization of flavonols
05/27/2003US6569152 Sustained release delivery systems for solutes
05/27/2003US6568398 Treating a wound with a wound healing agent comprising a granular astringent hemostatic agent micro-encapsulated with a biopolymer, observing the cover layer of microcapsules remain white, then removing the microcapsules
05/27/2003CA2066104C Benzazepine derivatives as vasopressin antagonists
05/27/2003CA2024309C Pharmaceutical compositions comprising modified and unmodified plasminogen activators and uses thereof
05/27/2003CA1341429C Hirudin variants, their use and processes for obtaining them
05/22/2003WO2003042405A2 Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof
05/22/2003WO2003042397A2 A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby
05/22/2003WO2003042358A2 Methods of using 48149, a human aminopeptidase family member
05/22/2003WO2003042191A1 Benzamide and heteroarylamide as p2x7 receptor antagonists
05/22/2003WO2003042190A1 N-alkyl-adamantyl derivatives as p2x7-receptor antagonists
05/22/2003WO2003042181A1 4,4-difluoro-1,2,3,4-tetrahydro-5h-1-benzazepine derivatives or salts thereof
05/22/2003WO2003042113A1 Production of cell suspensions
05/22/2003WO2003041723A1 Pharmaceutical applications of hyaluronic acid preparations
05/22/2003WO2003041715A1 Substituted 1,4-benzodiazepines and uses thereof for the treatment of cancer
05/22/2003WO2003041713A1 Use of therapeutic dosages for nitric oxide donors which do not significantly lower blood pressure or pulmonary artery pressure
05/22/2003WO2003041697A1 Method for treating autoimmune diseases
05/22/2003WO2003041689A1 Biocompatible polymer blends and uses thereof
05/22/2003WO2003041634A2 Bag system for cryopreservation of body fluids
05/22/2003WO2003011277A3 Methods to mobilize progenitor/stem cells
05/22/2003WO2003006670A3 2-[5-(5-carbamimidoyl-1h-heteroaryl)-6-hydroxybiphenyl-3-yl]-succinic acid derivatives as factor viia inhibitors
05/22/2003WO2002100327A3 Substituted 1-benzazepines and derivatives thereof
05/22/2003WO2002096362A3 Method for treating fibrotic diseases or other indications vi
05/22/2003WO2002083120A3 Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors
05/22/2003WO2002044183A3 Benzoazepine and benzodiazepine derivatives and their use as parp inhibitors
05/22/2003WO2002024215A3 Method for using activated protein c for the treatment of coagulation-associated disorders
05/22/2003WO2002022776A9 Human coagulation factor vii variants
05/22/2003US20030097004 3,4-Di-substituted cyclobutene-1,2-diones as CXC chemokine receptor antagonists
05/22/2003US20030096998 As immunomodulators and for inducing cytokine biosynthesis in animals, for therapy of viral infections
05/22/2003US20030096992 Method of preparing alkylated salicylamides via a dicarboxylate intermediate
05/22/2003US20030096982 Nucleotide sequences coding polypeptide for use in the treatment of immunological, reproductive and liver disorders
05/22/2003US20030096827 Heterocyclic amine derivatives; for treating an inflammatory or immune disease, a cardiovascular disease, or a neurodegenerative condition
05/22/2003US20030096824 Substituted phenylamidines medicaments containing said compounds and method for production thereof
05/22/2003US20030096820 Nitrogen containing heterobicycles as factor Xa inhibitors
05/22/2003US20030096817 Inhibiting mammalian protein kinases (p38) with (2,6-difluoro-phenyl)-(5-iodo-pyridin-2-yl)amine for treatment of cardiovascular disorders
05/22/2003US20030096816 Such as 2-methylsulfanyl-5-(2-phenylamino-pyrimidin-4-yl)-4-p-tolyl-thiophene-3 -carbonitrile; antiproliferative agents; stents
05/22/2003US20030096804 Bicyclic inhibitors of factor Xa
05/22/2003US20030096783 21132, a human G-protein coupled receptor family member and uses therefor
05/22/2003US20030096758 Anticarcinogenic agents
05/22/2003US20030096754 Vascular endothelial growth factor variants
05/22/2003US20030096752 Net charge of -3-3 at pH 7 and with the amino acids arginine15 or arginine15-alanine17 in the binding region; serine protease inhibitors
05/22/2003US20030096737 Caspase inhibitors and uses thereof
05/22/2003US20030096393 Polypeptide for use in the treatment of alzheimers's, tumor, multiple sclerosis, congestive heart failure, schemic reperfusion, blood and thrombotic disorders
05/22/2003US20030096338 Protein conjugate for use in the treatment of blood disorder
05/22/2003US20030096299 Natural ligand of G protein coupled receptor ChemR23 and uses thereof
05/22/2003US20030095997 Preferably collagen; capable of promoting formation of granulation tissue, angiogenesis, vascularization and epithelization; useful in surgical suturing.
05/22/2003CA2756866A1 A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby
05/22/2003CA2472019A1 Production of cell suspensions
05/22/2003CA2468171A1 Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof
05/22/2003CA2466998A1 Biocompatible polymer blends and uses thereof
05/22/2003CA2466519A1 Method for treating autoimmune diseases
05/22/2003CA2466055A1 Substituted 1,4-benzodiazepines and uses thereof for the treatment of cancer
05/22/2003CA2465868A1 A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby
05/22/2003CA2464069A1 4,4-difluoro-1,2,3,4-tetrahydro-5h-1-benzazepine derivative or salt thereof
05/21/2003EP1312602A1 Amidino derivatives, and anticoagulants and thrombosis therapeutic agents containing them
05/21/2003EP1312601A1 Carboxylic acid derivatives, process for producing the same and drugs containing the same as the active ingredient
05/21/2003EP1312379A1 Fibrinogen lowering agents
05/21/2003EP1312367A1 Heterocyclo-alkylsulfonyl pyrazolesa and their use as COX-2 inhibitors
05/21/2003EP1311534A1 Thioether-sulphamate steroids as steroid sulphatase inhibitors and anti-cancer compounds
05/21/2003EP1311533A1 17-aryl-linker derivatised estrogen 3-sulphamates as inhibitors of steroid sulphatase
05/21/2003EP1311532A1 Oestrogen-17-sulphamates as inhibitors of steroid sulphatase
05/21/2003EP1311525A2 Composition and method for inhibiting platelet aggregation
05/21/2003EP1311507A1 Fused pyrazole derivatives being protein kinase inhibitors
05/21/2003EP1311501A1 Antithrombotic agents
05/21/2003EP1311489A1 Biphenyl derivatives and the use thereof as integrin inhibitors
05/21/2003EP1311488A1 Substituted imidazoles as tafia inhibitors
05/21/2003EP1311485A1 Processes for preparing cilostazol
05/21/2003EP1311484A1 Biphenyl derivatives and the use thereof as integrin inhibitors
05/21/2003EP1311480A1 New amidino derivatives and their use as thrombin inhibitors
05/21/2003EP1311476A1 Aza-amino acid derivatives (factor x a?-inhibitors 15)
05/21/2003EP1311473A2 Novel compounds inhibiting factor xa activity
05/21/2003EP1311298A2 System for regulating in vivo the expression of a transgene by conditional inhibition
05/21/2003EP1311285A2 Liquid pharmaceutical composition containing an erythropoietin derivative
05/21/2003EP1311284A2 Saratin for inhibiting platelet adhesion to collagen
05/21/2003EP1311273A2 Combination of a purine and an nsaid for treating sexual dysfunction
05/21/2003EP1311269A2 Method of using diketopiperazines and composition containing them
05/21/2003EP1311202A1 Method and system for anticoagulant dose revision
05/21/2003EP0765166B1 Radiolabeled annexin-galactose conjugates
05/21/2003EP0411031B1 THE HUMAN C3b/C4b RECEPTOR (CR1)
05/21/2003CN1419554A Process for preparing crystalline form 1 of cabergoline
05/21/2003CN1419547A Compounds exhibiting thrombopoietin receptor agaonism
05/21/2003CN1419541A Pharmaceutically active pyrrolidine derivatives as BAX inhibitors
05/21/2003CN1419539A Amidino compound and salts thereof useful as nitric oxide synahase inhibitors
05/21/2003CN1418882A Substituted sulfonic N-[(amino imino methyl) phenyl alkyl]-acacycloamide compound
1 ... 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 ... 671